128 related articles for article (PubMed ID: 2219280)
1. Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up.
Greenberg A; Thompson ME; Griffith BJ; Hardesty RL; Kormos RL; el-Shahawy MA; Janosky JE; Puschett JB
Transplantation; 1990 Oct; 50(4):589-93. PubMed ID: 2219280
[TBL] [Abstract][Full Text] [Related]
2. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
Tinawi M; Miller L; Bastani B
Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
[TBL] [Abstract][Full Text] [Related]
3. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression.
Goldstein DJ; Zuech N; Sehgal V; Weinberg AD; Drusin R; Cohen D
Transplantation; 1997 Mar; 63(5):664-8. PubMed ID: 9075835
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
7. The incidence of renal failure in one hundred consecutive heart-lung transplant recipients.
Pattison JM; Petersen J; Kuo P; Valantine V; Robbins RC; Theodore J
Am J Kidney Dis; 1995 Oct; 26(4):643-8. PubMed ID: 7573020
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
9. Chronic cyclosporine-induced nephrotoxiciy in heart transplant patients: long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine.
Sanchez V; Delgado JF; Morales JM; Tello R; Gómez MA; Escribano P; de la Cámara AG; de la Calzada CS
Transplant Proc; 2004 Nov; 36(9):2823-5. PubMed ID: 15621159
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of cyclosporine toxicity by concomitant administration of erythromycin.
Jensen CW; Flechner SM; Van Buren CT; Frazier OH; Cooley DA; Lorber MI; Kahan BD
Transplantation; 1987 Feb; 43(2):263-70. PubMed ID: 3544386
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine nephropathy after heart and heart-lung transplantation.
Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
[TBL] [Abstract][Full Text] [Related]
12. Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy--five year follow-up.
Lewis RM; Janney RP; Golden DL; Kerr NB; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1989 Feb; 47(2):266-72. PubMed ID: 2645711
[TBL] [Abstract][Full Text] [Related]
13. Use of cyclosporine in pediatric renal transplant recipients.
Conley SB; Flechner SM; Rose G; Van Buren CT; Brewer E; Kahan BD
J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
[TBL] [Abstract][Full Text] [Related]
14. Predictors of renal function following lung or heart-lung transplantation.
Ishani A; Erturk S; Hertz MI; Matas AJ; Savik K; Rosenberg ME
Kidney Int; 2002 Jun; 61(6):2228-34. PubMed ID: 12028464
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal failure following liver transplantation: a retrospective analysis.
Fisher NC; Nightingale PG; Gunson BK; Lipkin GW; Neuberger JM
Transplantation; 1998 Jul; 66(1):59-66. PubMed ID: 9679823
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine-associated chronic nephropathy.
Myers BD; Ross J; Newton L; Luetscher J; Perlroth M
N Engl J Med; 1984 Sep; 311(11):699-705. PubMed ID: 6382005
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
Flechner SM; Goldfarb D; Modlin C; Feng J; Krishnamurthi V; Mastroianni B; Savas K; Cook DJ; Novick AC
Transplantation; 2002 Oct; 74(8):1070-6. PubMed ID: 12438948
[TBL] [Abstract][Full Text] [Related]
19. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
Pachon J; Lorber MI; Bia MJ
Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporine on renal function following orthotopic heart transplantation.
McKenzie N; Keown P; Stiller C; Kostuk W; Campbell C; Keith F
J Heart Transplant; 1985; 4(4):400-3. PubMed ID: 3916514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
